Evidence Hub

Comparison of the efficacy of HoLEP and TURP in the treatment of elderly benign prostatic hyperplasia patients: a retrospective study

Xierzhati Aizezi, Liancheng Feng, Zheng Wang, Yuan Ma, Jifu Li, Abuduweili Keremu, Maihemujiang Rouzi, A. Dilixiati et al.

Aktuelle Urologie, 2023

565 participants · 2 citations

Abstract

Abstract Objective To prove that holmium laser prostatectomy (HoLEP) is safe and effective in the treatment of benign prostatic hyperplasia (BPH), and is superior to transurethral prostatectomy (TURP) for elderly patients. Methods We retrospectively studied 565 HoLEP patients and 76 TURP elderly patients. HoLEP patients were first divided into three groups according to their age(Under 65 years old group, 65–79 years old group and over 80 years old group), and their preoperative, intraoperative, and postoperative characteristics were then compared. Secondly, the same characteristics of HoLEP and TURP patients over 80 years were compared. Chi-square test, one-way ANOVA and Fisher’s exact test were used in this study. Results Firstly, we compared HoLEP patients in different age groups and found that there was statistically significant difference in diabetes, CCVD and bladder stones, among the three groups (P0.05), the difference was statistically significant, 6 months after the operation (P<0.05). Conclusion HoLEP is safe and effective for BPH patients, and is superior to transurethral TURP for elderly patients.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free